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Hydroxypropyl-β-cyclodextrinIn this study we show that postnatal development of cerebellar granule neurons (GNs) is defective in Npc1−/−
mice. Compared to age-matched wild-type littermates, there is an accelerated disappearance of the external
granule layer (EGL) in these mice. This is due to a premature exit from the cell cycle of GN precursors residing
at the level of the EGL. As a consequence, the size of cerebellar lobules of thesemice displays a 20%–25% reduction
compared to that of age-matched wild-type mice. This size reduction is detectable at post-natal day 28 (PN28),
when cerebellar GN development is completed while signs of neuronal atrophy are not yet apparent.
Based on the analysis of EGL thickness and the determination of proliferating GN fractions at increasing develop-
mental times (PN8–PN14),we trace the onset of this GN developmental defect during the secondpostnatalweek.
We also show that during this developmental time Shh transcripts undergo a signiﬁcant reduction in Npc1−/−
mice compared to age-matchedwild-typemice. In light of themitogenic activity of Shh on GNs, this observation
further supports the presence of defective GNproliferation inNpc1−/−mice. A single injection of hydroxypropyl-
β-cyclodextrin at PN7 rescues this defect, restoring the normal patterns of granule neuron proliferation and cer-
ebellar lobule size.
To our knowledge, these ﬁndings identify a novel developmental defect that was underappreciated in previous
studies. This defect was probably overlooked because Npc1 loss-of-function does not affect cerebellar foliation
and causes the internal granule layer and molecular layer to decrease proportionally, giving rise to a normally
appearing, yet harmoniously smaller, cerebellum.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Niemann–Pick C1 (NPC1) is a multipass transmembrane protein re-
siding in late endosomes and lysosomes (Garver et al., 2000; Higgins
et al., 1999; Neufeld et al., 1999) and is essential to prevent the storage
of cholesterol in those compartments (Morris et al., 1982; Pentchev
et al., 1986). Working with NPC2, NPC1 mediates the egress of LDL-
derived cholesterol from the endolysosomal compartment (Sleat et al.,
2004) by a mechanism(s) not yet fully characterized, although great
progress is being made (Cheruku et al., 2006; Infante et al., 2008). The
widely accepted model is that NPC2 binds free cholesterol after lyso-
somal hydrolysis of LDL cholesteryl esters and transfers it to NPC1,
which mediates the exit of cholesterol from lysosomes (Defﬁeu and
Pfeffer, 2011; Kwon et al., 2009). Mutations of NPC1 and NPC2 genes.T. Fiorenza).
ect.com).
. This is an open access article underin our species are associated with Niemann–Pick disease type C (95%
and 5% of patients, respectively) (Vanier, 2010).
A prominent feature of NPC1 disease is themassive loss of cerebellar
Purkinje cells (PCs) (Higashi et al., 1993; Ong et al., 2001). A similar fea-
ture is also observed in severalmousemodels of NPC1 disease, in which
PC degeneration and loss begin at 28–40 days of postnatal age (PN28–
40) and become very pronounced at PN60 (Higashi et al., 1993). Several
approaches, including chimericmice, conditional knock-outmodels and
various neuron/glial-speciﬁc transgenic rescue experiments (Borbon
et al., 2012; Elrick et al., 2010; Yu et al., 2011; Zhang et al., 2008) have
been used to investigate the contribution of speciﬁc cell types to NPC1
neuropathology. Using chimeras of Npc1−/− and normal cells, it was
proposed that Npc1−/− PC death is a cell-autonomous property (Ko
et al., 2005), occurring even when PCs are surrounded by wild-type
Bergmann glia (BG). Moreover, wild-type PCs survive well although
surrounded byNpc1−/− BG (Ko et al., 2005). Despite these observations,
the role astroglial cells exert inNPCneuropathology is still controversial.
Exploiting a neuron-glia co-culture system, it was observed that Npc1-
deﬁcient astrocytes do not support neurite growth as efﬁciently asthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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expressing Npc1 from a glial ﬁbrillary acidic protein promoter in
Npc1−/− mice displayed lower levels of neuronal cholesterol accumula-
tion and lived longer (Zhang et al., 2008). On the other hand, the trans-
genic re-expression of Npc1 in neurons or in astrocytes of Npc1−/−mice
led to the conclusion that neuronal rescue only reduced neurological
symptoms (Lopez et al., 2011). Moreover, the presence of a conditional
Npc1 null allele in neurons was shown to mostly recapitulate the neuro-
pathology typical of NPC (Yu et al., 2011), but the deletion in oligodendro-
cytes resulted in the impairment of myelin formation and maintenance
(Yu and Lieberman, 2013).
Because neuropathological signs ﬁrst appear in 5-week-old
Npc1−/−mice, it is currently believed that developmental process-
es are not affected by the loss-of-function of the Npc1 gene. How-
ever, a study by Baudry et al. (2003) has shown that 2-week-old
Npc1−/− mice display a signiﬁcant level of microglia activation in
several brain areas, including cerebellum. Microglia regulate neuronal
proliferation and differentiation (Banati and Graeber, 1994), raising
the question as to whether these processes may be inﬂuenced by mi-
croglia activation. At 2 weeks of age, in fact, cerebellar cortical
development is still ongoing with active granule neuron (GN) prolifer-
ation/differentiation/migration and PC dendritic expansion, making the
study of postnatal cerebellar development in Npc1−/−mice worthy of
further investigation.
Among cerebellar cells, GNs have been studied little in murine
models of NPC1 disease, perhaps because their development takes
place during the ﬁrst 3 weeks of postnatal life (Altman and Bayer,
1997; Sotelo, 2004; Wang and Zoghbi, 2001), whereas signs of cerebel-
lar pathology occur in older mice. Indeed, GNs are progressively gener-
ated from E18.5 until PN16.5 from a progenitor layer covering the
cerebellar surface, which is named the external granule layer (EGL)
(Solecki et al., 2001). During early postnatal development, the coexis-
tence of two GN precursor populations splits the EGL into two sub-
regions, the outer EGL (containing mitotic cells; oEGL) and the inner
EGL (containing post-mitotic cells; iEGL). GN precursors forming the
oEGL and iEGL can be distinguished from each other by the expression
of different protein markers, such as PCNA for mitotic and p27Kip1 for
post-mitotic cells (Argenti et al., 2005; Miyazawa et al., 2000). Besides
these two GN populations, an additional one, named “intermediate pro-
genitors” and residing in a region of overlap between the oEGL and iEGL,
has been recently characterized (Xenaki et al., 2011).
At around the time of birth someGNs exit from the cell cycle andmi-
grate inward to form the internal granule layer (IGL) that represents
their ﬁnal destination, determining the gradual disappearance of the
EGL (Altman and Bayer, 1997). GN proliferation in postnatal cerebellum
EGL is sustained by various factors, including Sonic Hedgehog (Shh) se-
creted by PCs (Dahmane et al., 1999; Vaillant and Monard, 2009;
Wechsler-Reya and Scott, 1999) and several microglia-released growth
factors that activate the Notch signaling pathway (Morgan et al., 2004).
Upon exit from the cell cycle, GNs migrate radially along the Bergmann
glia and through the PC layer to reach the internal granule layer (IGL)
(Adams et al., 2002) where they contribute to the formation of cerebel-
lar glomeruli, a complex of synapses withmossy ﬁber endings converg-
ing on GN dendrites (Landis et al., 1983). Mossy ﬁber inputs are then
transmitted to PCs via synaptic contacts between GN parallel ﬁbers
and PC dendrites.
Even though a prominent effect of Npc1 loss-of-function on GN de-
velopment has not been reported, membranous inclusions in the cyto-
plasm of these cells were observed by electron microscopy in
cerebella of 5-week-old Npc1−/−mice (Tanaka et al., 1988). Moreover,
in amore recent study, the IGL of aNpc1−/− cat was found to be thinner
compared to that of wild-type controls, opening the possibility that GNs
were generated in a lower number during postnatal cerebellar develop-
ment or died because of an increased level of apoptosis (Vite et al.,
2008). An additional line of evidence enlightening the possible contri-
bution of a GN defect to NPC neuropathology derives from a recentstudy showing that the synaptic transmission from parallel ﬁbers to
PCs is increased and that long-term depression (LTD) is deﬁcient in 3-
week-old Npc1−/−mice (Sun et al., 2001).
In this studywe show that the EGL of Npc1-deﬁcient mice has fewer
GNs and persists for a shorter time compared to age-matchedwild-type
mice and that a single treatment with hydroxypropyl-β-cyclodextrin
(HPBCD) at PN7 re-establishes the normal EGL thickness/GN number
in Npc1−/− cerebella. We also show that the level of Shh transcripts of
Npc1−/− cerebella undergoes a signiﬁcant reduction during the second
post-natal week, likely affecting the proliferation of GN precursors. To
our knowledge, these ﬁndings provide the ﬁrst evidence of a develop-
mental GN defect in Npc1−/−mice, enlarging the perspective for future
studies on the molecular mechanisms that underlie NPC1 disease.
Materials and methods
Animals and treatments
Npc1−/−mice on the BALB/cJ backgroundwere generated bymating
heterozygous animals. Genotypeswere identiﬁed from tail DNAbyPCRas
described (Loftus et al., 1997). Treatment with HPBCD (Sigma Aldrich,
Milan, Italy) was performed in 7-day-old mice by a subcutaneous injec-
tion of 4 g HPBCD/kg body weight. BrdU labeling was achieved by intra-
peritoneal injection with 5-bromodeoxyuridine (60 mg BrdU/g body
weight, Sigma Aldrich Inc., Milan, Italy). Mice were maintained in our
animal facility in accordance with Sapienza University guidelines for the
care and use of laboratory animals. Experimental protocols and related
procedures were approved by the Italian Ministry of Public Health.
Histology and immunohistochemistry
Npc1+/+ and Npc1−/−mouse brains of postnatal days 11, 14 and 28
(PN11–28), either treated or untreated with HPBCD, were quickly dis-
sected, ﬁxed overnight at 4 °C in 4% PFA in 0.1 M phosphate buffer
(PBS), dehydrated and embedded in Paraplast Plus Tissue Embedding
Medium (Società Italiana Chimici, Rome; Italy). Parafﬁn tissue blocks
were serially sectioned (slice thickness 8 μm), obtaining parasagittal sec-
tions that were mounted on Superfrost Excell adhesion slides (Thermo
Scientiﬁc, Milan, Italy), de-waxed with xylene, re-hydrated and washed
in PBS. For grossmorphologyof cerebellar lobules, sections encompassing
the middle of the cerebellar vermis were stained with Nuclear Fast Red
Solution (0.1% nuclear fast red, 5% aluminum sulfate; Sigma Aldrich Inc.,
Milan, Italy) for 30 min. Determination of the region of interest (ROI) in
histological sections for area measurements (total cerebellum, total lob-
ule IV/V, and IGL and ML of lobule IV/V) was independently performed
by two investigators on three consecutive mid-sagittal sections of at
least ﬁve mice per group, using ImageJ NIH software version 1.47v (Na-
tional Institutes of Health, Bethesda, MD). Images to be compared were
carefully selected paying attention that they were the closest possible
to the parasagittal position, as inferred by the deeper white matter tracts
matching very well in each image. The region of interest (ROI) in each
section was outlined using the “selection brush” or the “polygon tool”,
obtaining similar results.
To determine the number of GN cells, sections from PN11 and PN14
micewere stained with 0.5 μg/mLHoechst (Hoechst-33258, Invitrogen,
Milan, Italy) for 4 min. To assess GN proliferation, brainswere dissected
fromNpc1+/+ andNpc1−/−mice, either treated or untreatedwithHBCD
and that had received a single BrdU injection at PN10, PN12 and PN14,
and processed as described above, obtaining parasagittal sections to
be stained with anti-BrdU antibodies. Epitopes were unmasked by
heating sections 2 × 5 min in 0.1 M citric acid, pH 6.0, in a microwave
oven. Tissue permeabilizationwas achieved by incubation in trypsin so-
lution (0.05% trypsin, 0.1% CaCl2 in water) for 15 min at room tempera-
ture (RT) and then in 2 M HCl for 30 min. After washing with PBS,
sections were incubated overnight at 4 °C with a monoclonal anti-
BrdU antibody (Immunological Science, Rome, Italy; 1:100 dilution in
Fig. 1.The cerebellumof adultNpc1−/−mice is reduced in size. (A)Grossmorphological comparisonof PN28Npc1+/+ andNpc1−/−mouse cerebella (brackets). Cx: cortex; Cb: cerebellum;
Bs: brain stem. (B) Sagittal sections of cerebellar vermis fromPN28Npc1+/+ andNpc1−/−mice, either untreated or treatedwith a single injection of HPBCD at PN7. Representative sections
encompassing sagittal midline of vermis are shown in the ﬁgure. Superimposition of total vermis tracings indicates an overall size reduction inNpc1−/−mice compared towild-typemice
that was largely rescued by HPBCD treatment. (C) Histograms indicate total areas (mean± SEM; 5–6mice/group)measured on representative sections ofNpc1+/+ (empty bar),Npc1−/−
(full bar) and HPBCD-treated Npc1−/−mice (dashed bar). Asterisk indicates statistically signiﬁcant differences (*p b 0.05). Scale bars indicate 2 mm (panel A) and 0.5 mm (panel B).
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anti-mouse IgG antibody (Alexa Fluor-555 InVitrogen, Milan, Italy;
1:1500 ﬁnal dilution). Sections were ﬁnally counterstained with
Hoechst-33258, mounted with Prolong Gold Antifade Reagent and ana-
lyzed with an epiﬂuorescence Zeiss microscope. For quantiﬁcation of
BrdU-immunopositive cells, ROIs were randomly selected from bases
and crowns of the anterior (between lobules II and III), middle (be-
tween lobules VI and VII) and posterior (between lobules IX and X) lob-
ules of 4 cerebella for each developmental stage. The total number of
cells in each regionwas calculated by determining the number of nuclei
based on Hoechst staining.
For p27Kip1 immunodetection, histological sections were subjected
to unmasking and permeabilization procedures similar to those de-
scribed for BrdU immunostaining. Following an incubation with 5% hy-
drogen peroxide for 15 min to inhibit endogenous peroxidase, sections
were incubated with a buffer made of 6% goat serum and 0.3% Triton-
X100 in PBS for 30 min to block non-speciﬁc binding. Immunohisto-
chemistry was performed using the avidin–biotin horseradish peroxi-
dase complex (ABC) method. Brieﬂy, sections were incubated with
rabbit monoclonal primary antibody against p27Kip1 (Epitomics,
Burlingame, CA, USA; 1:75 ﬁnal dilution) overnight at 4 °C, washed 3
times with PBS, and stained using the rabbit Vectastain Elite ABC Kit
(Vector Laboratories Inc., Burlingame, CA, USA) ﬁrst, allowing thespeciﬁc ABC complex development, and then the DAB Peroxidase Sub-
strate Kit (Vector Laboratories Inc., Burlingame, CA, USA), according to
the protocol supplied by the manufacturer. Nuclear counterstaining
was performed by incubating sections with 0.5% methyl green solution
(0.5% methyl green, 0.1 M sodium acetate buffer in water, pH 4.2) for
5 min at 60 °C.
In situ Terminal deoxynucleotidyl transferase(TdT)-mediated dUTPNick-End
Labeling (TUNEL)
Cell death in the developing cerebellum of Npc1+/+ and Npc1−/−
mice was assessed by the in situ TUNEL method selective for apoptotic
cells. Sections were covered with 20 μg/mL Proteinase K for 1 h at
37 °C to permeabilize the tissue. After 2 washes in PBS for 5 min each,
sections were incubated with 100 μL Tunel Equilibration Buffer for
5 min and then with 100 μL TUNEL Reaction Buffer containing 2% TdT
enzyme for 2 h at 37 °C (Immunological Science, Rome, Italy). Sections
were washed 3 times for 5 min each in PBS containing 0.1% Triton X-
100 and 5 mg/mL BSA. Slideswere then stainedwith 0.5 μg/mLHoechst
(Hoechst-33258, Invitrogen, Milan, Italy) for 4 min, mounted with Pro-
long Gold Antifade Reagent (InVitrogen, Milan, Italy) and examined
using an epiﬂuorescence Zeiss microscope. Images were acquired with
a Cool Snap K4 Photometrics camera.
Fig. 2. Both anterior and posterior lobules of Npc1−/− cerebellum display a reduced size. (A) Parasagittal histological sections of PN28 mouse cerebella of Fig. 1 were examined at higher
magniﬁcation to evaluate the effect of genotype and/or HPBCD treatment on foliation and single lobule size. Representative sections are shown in the ﬁgure. Npc1−/−mice displayed an
overall normal foliation pattern. However, the size of both anterior and posterior lobules was impaired and a single injection of HPBCD to PN7 Npc1−/−mice re-established the normal
lobule size. (B) The extent of size reduction was measured in detail on lobule IV/V. Histograms indicate the total lobule and IGL and ML areas (mean ± SEM of all sections examined;
5–6 mice/group) measured on randomly selected parasagittal sections of Npc1+/+ (empty bars), Npc1−/− (full bars) and HPBCD-treated Npc1−/−mice (dashed bars). Asterisks indicate
statistically signiﬁcant differences (*p b 0.05; **p b 0.005). Scale bar indicates 0.5 mm.
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Total RNAwas extracted from PN8, PN12,Npc1+/+ andNpc1−/− cer-
ebella, either treated or untreated with HPBCD, using TRIzol (Life tech-
nologies, CA, USA) and treated with DNase I (Ambion, Life
technologies, CA, USA) for 15 min at 37 °C to remove genomic DNA.
cDNA was synthesized using the GoScript Reverse Transcription System
(Promega, WI, USA) following the protocol supplied by the manufactur-
er. Real-time PCR was performed using QuantiFast Sybr Green PCRMas-
ter Mix (Qiagen Inc., CA, USA) with the following cycling conditions: 95
°C for 10min, then 35 cycles of 95 °C for 10 s and 62 °C for combined an-
nealing/extension for 40 s. The QuantiFast PCR primers were:
Mm_Shh_1_SG Cat No. QT00122479 (Shh), Mm_Actb_2_SG Cat No.
QT01136772 (β-actin), andMm_Rps16_QT0009256 (S16 ribosomal pro-
tein). The level of Shh genewas normalized to the expression level of the
housekeeping genes β-actin and rps16.Statistics
Statistical analyses were performed using GraphPad Prism ver-
sion 5.0d (GraphPad, La Jolla, CA). Data are expressed as mean
values ± SEM. Statistically signiﬁcant differences were analyzed
using one-way ANOVA followed by Bonferroni's post hoc test. p
values less than 0.05 were considered signiﬁcant.Results
Cerebellar lobule size is reduced in Npc1−/−mice and is rescued by a single
HPBCD injection
During postnatal development, the increase of cerebellum volume is
largely due to the proliferation of GNs at the level of the EGL (Solecki
et al., 2001). In the mouse, GN proliferation is mainly regulated by Shh
expression and activity that, thereby, determine ﬁnal cerebellar size
and shape (Ruiz et al., 2002; Vaillant and Monard, 2009; Wallace,
1999; Wechsler-Reya and Scott, 1999). Reasoning that cholesterol is of
particular relevance for both Shh signal generation and transduction
in receiving cells, we analyzed the size and anatomy of cerebellar lob-
ules in PN28 Npc1−/− and age-matched Npc1+/+ mice. At this time,
the cerebellar cortex has already achieved the conformation of the
adult, consisting of a so-called molecular layer (ML), mainly formed by
ﬁbers with few scattered cells, and the internal granule layer (IGL),
mainly containing GNs. Gross morphological analysis revealed that the
overall cerebellar size of Npc1−/−mice was reduced compared to that
of age-matched wild-type mice (Figs. 1A,B). To quantify such reduction
in size, the total areas of parasagittal sections of wild-type,Npc1−/− and
HBPCD-treated Npc1−/− cerebella were measured after nuclear fast red
staining, observing that Npc1−/− mice displayed a 20% reduction and
that a single subcutaneous injection of HPBCD at PN7 largely rescued
this phenotype (Figs. 1B,C).
Fig. 3.Npc1−/−mice display reduced granule neuron density in the EGL that is rescuedby theHPBCD treatment. (A,C) Cerebellar sections of PN11, PN14Npc1+/+, andNpc1−/−mice, either
untreated or treatedwith a single injection of HPBCD at PN7, were stainedwith Hoechst 33258. Representative sections are shown in the ﬁgure. Highermagniﬁcation ﬁelds of EGL base or
crownof lobules II andX are shownon the right of lowmagniﬁcationﬁelds. Nomajor differenceswere detected at PN11. At PN14however, the EGL of both anterior and posterior lobules of
Npc1−/−micewas thinner than that of age-matchedNpc1+/+, whileHPBCD treatment fully rescued this phenotype. (B,D) Histograms represent granule neuron densities (mean±SEMof
all sections examined; 4–5 mice/group; 3–4 sections/mouse) determined in 100 μm2 regions of the crowns of the anterior (I–V) and posterior (VI–X) lobules of Npc1+/+ (empty bars),
Npc1−/− (full bars) and HPBCD-treated Npc1−/− (dashed bars) mice. Asterisks indicate statistically signiﬁcant differences (*p b 0.05; **p b 0.005). Scale bars indicate 250 μm (panels)
and 50 μm (inserts).
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ebellar vermis were also useful for visualizing the morphology of cere-
bellar lobules, showing that both ﬁssuration and lobule/sublobule
formation were normal and that the ﬁnal step of lobule growth was ac-
tually impaired by Npc1 loss-of-function. This feature extended to all
lobules without graded antero-posterior or postero-anterior patterns
(Fig. 2A). To further investigate the issue of cerebellar size reduction,
total, IGL and ML areas of a representative lobule were determined, as
performed by Peeters et al. (2013). Lobule IV/V was chosen because of
its conspicuous length and less elaborate shape, making area measure-
ments more reliable. These analyses indicated that the total area of lob-
ule IV/V displayed a 24% size reduction and that IGL andML displayed a
similar extent of size reduction, 26% and 20%, respectively (Figs. 2A,B).
IGL:ML area ratios appeared not to vary signiﬁcantly in each group
(wild-type mice, 0.66; Npc1−/− mice, 0.62; HPBCD-treated Npc1−/−
mice, 0.69; p = 0.4), leading to the conclusion that Npc1 loss-of-
function determines an “in-proportion” size reduction, which is in
agreement with the normally appearing, yet smaller cerebellum of
Npc1−/− mice. HPBCD treatment fully rescued the reduction in size,
even determining a slight size increase.
Npc1−/−mice display a shorter-lasting EGL
Starting at around the time of birth, someGN precursors exit the cell
cycle and begin to differentiate into mature GNs (Altman and Bayer,
1997). Then post-mitotic GNs migrate through the single row of PCs
to reach the IGL. This determines the gradual thinning anddisappearance of EGL by the third post-natal week. We investigated
the issue of reduced cerebellar lobule size of Npc1−/− by determining
the EGL thickness in parasagittal sections obtained from cerebella of
mice at increasing post-natal days of development, namely PN8, PN11
and PN14. The EGL was visualized by staining GN nuclei with Hoechst,
while the number of GNs was determined by counting nuclei in ran-
domly selected regions of 100 μm2 each (Fig. 3). This analysis showed
that EGL thickness and GN densities were similar in PN8 (not shown)
and PN11 Npc1+/+ and Npc1−/− mice, whereas in PN14 Npc1−/−
mice, the EGL was mostly undetectable compared to that of age-
matched Npc1+/+ mice. Indeed, only a few scattered GNs, not even
forming a single row of cells, were observed in both crowns and ﬁssures
of either the anterior or posterior lobules ofNpc1−/−mice. In agreement
with the rescuing effect HPBCD had on cerebellar lobule size, a single
HPBCD injection at PN7 doubled the number of GNs in the EGL of
PN14 Npc1−/−mice.
Loss of Npc1 function results in GN proliferation defect
The ﬁnding that Npc1−/−mice displayed a shorter-lasting EGL com-
pared to age-matched Npc1+/+ mice despite the presence of normal
EGL thickness/GN numbers until PN11, suggested that the clock driving
the proliferation of GN precursors was somehow dysregulated in
Npc1−/− mice, leading these cells to prematurely exit from the cell
cycle. Alternatively, an increase in the number of cells undergoing apo-
ptosis could also account for the reduction of GNs forming the EGL. In
either case, the time window in which these events take place likely
Fig. 4. Npc1−/−mice display reduced number of proliferating granule neurons that is rescued by the HPBCD treatment. (A) Histograms represent the number of BrdU-positive
cells (mean ± SEM; 4–5 mice/group; 3–4 sections/mouse) determined in 100 μm2 regions corresponding to the bases and crowns of the anterior (I–V) and posterior (VI–X) lobules of
Npc1+/+ (empty bars), Npc1−/− (full bars) and HPBCD-treated Npc1−/− (dashed bars) mice. Asterisks indicate statistically signiﬁcant differences (*p b 0.05; **p b 0.005). Note that the
number of BrdU-positive GNswas signiﬁcantly reduced in both crowns and ﬁssures of the anterior cerebellar lobules of PN12 and PN14Npc1−/−mice compared to age-matchedNpc1+/+
mice. (B) A representative ﬁeld showing BrdU-positive cells (red) of ﬁssure between lobules I and II of PN12Npc1+/+ (left),Npc1−/− (middle) and HPBCD-treated Npc1−/−mice (right).
Note that HPBCD treatment re-established the normal number of proliferating cells. Scale bar indicates 50 μm.
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PN11 and PN14.
To address these questions, we determined the number of cells in-
corporating BrdU 20 h after a single BrdU injection of PN10, PN12 or
PN14 Npc1+/+ and Npc1−/− mice, either untreated or treated with
HPBCD. While similar in PN10 mice, the number of BrdU-positive cells
in both crowns and ﬁssures of the anterior cerebellar lobules was signif-
icantly reduced in PN12 and PN14 Npc1−/− mice compared to age-
matched Npc1+/+ mice. In posterior cerebellar lobules a reduction of
BrdU-positive cells was only observed in ﬁssures of PN14Npc1−/−mice.HPBCD treatment led Npc1−/− mice to display a number of BrdU-
positive cells similar to that of Npc1+/+ mice (Fig. 4). The possibility of
apoptosis was then investigated by analyzing midsagittal sections of
PN12, PN14 and PN28 mouse cerebella with TUNEL. This assay showed
that few TUNEL-positive cells were observed in cerebella of Npc1+/+
and Npc1−/− mice, either treated or untreated with HPBCD (Figs. 5A,
B). The number of TUNEL-positive cells decreased with age but neither
varied signiﬁcantly between Npc1+/+ and Npc1−/− nor was affected
by the treatment with HPBCD (Fig. 5B). Noteworthy, TUNEL-positive
cells were scarcely observed in the EGL of either Npc1+/+ or Npc1−/−
Fig. 5. Cerebella of Npc1−/− and Npc1+/+ display comparable numbers of apoptotic GNs. (A) Cerebellar sections of PN12, PN14 and PN28Npc1+/+ andNpc1−/−mice, either untreated or
treatedwith a single injection of HPBCD at PN7, were stainedwith TUNEL. A representative ﬁeld showing TUNEL-positive cells (red) of lobule II of PN14 Npc1+/+ (top),Npc1−/− (middle)
and HPBCD-treatedNpc1−/−mice (bottom). Arrowheads indicate TUNEL-positive cells. Scale bar indicates 50 μm. (B) Histograms represent the number of TUNEL-positive cells (mean±
SEM; 4–5mice/group; 3–4 sections/mouse) determined in 1 mm2 regions corresponding to the crown of lobule II of Npc1+/+ (empty bars), Npc1−/− (full bars) and HPBCD-treated
Npc1−/− (dashed bars) mice.
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These observations indicate that increased cell death is not the primary
cause of the reduction in GN number, instead suggesting an earlier exit
of these cells from themitotic cycle as amore likely possibility. This pos-
sibility was further strengthened by the observation that Shh transcript
levels were signiﬁcantly reduced in cerebella of PN8 and PN12 Npc1−/−
compared to age-matched Npc1+/+mice and returned to normal levels
after HPBCD treatment (Fig. 6).
Loss of Npc1 function results in disorganized cellular architecture of the EGL
As stated in the Introduction section, under normal developmental
conditions a sharp boundary separates the population of mitotically-
active p27Kip1-negative GNs forming the outer EGL from the
p27Kip1-positive post-mitotic GNs forming the inner EGL. Accordingly,
when we performed p27Kip1 immunostaining coupled to a
counterstaining of nuclei with methyl green on PN8 cerebella, this
boundary was easily identiﬁed in both Npc1+/+ and Npc1−/− mice
(Fig. 1SM). By contrast, p27Kip1 immunostaining of PN11 cerebella of
Npc1−/−mice revealed that the stereotyped and ordered EGL architec-
ture in the inner and outer sub-regions markedly differed between
Npc1+/+ and Npc1−/−mice (Fig. 7). Indeed, p27Kip1-immunopositive
cells were scattered along the entire EGL and apparently representedthe largest population of GNs. Therefore, at PN11, the niche ofmitotical-
ly active, p27Kip1-negative GNs (identifying the oEGL) ofNpc1+/+mice
is strongly reduced or even lost in Npc1−/−mice. Interestingly, HPBCD
treatment of Npc1−/− mice also reduced the fraction of p27Kip1-
immunopositive cells but did not fully re-established the sharp bound-
ary between the outer and inner EGLs (Fig. 7). A scheme comparing GN
proliferation inNpc1+/+ andNpc1−/− EGLs, based on theﬁndings of our
study, is shown in Fig. 8.
Discussion
This study shows that Npc1 deﬁciency affects GN expansion during
postnatal cerebellum development and that this leads ﬁrst to a signiﬁ-
cant reductionofNpc1−/− IGL andﬁnally of the entire cerebellar volume
in Npc1−/− adult mice. The reduction of IGL size is also accompanied by
a decrease of ML thickness, likely arising from the lower number of GN
parallel ﬁbers projecting to this area. Present observations agree with a
recent report based on in vivomagnetic resonance that the volumes of
several brain regions ofNpc1−/−mice, including cerebellum, are smaller
than those of age-matched wild-type mice since as early as 3 weeks of
age (Totenhagen et al., personal communication).
In contrast to the approximately 16.5-day period of GN proliferation
in the post-natal cerebellum of mice, we have found that GN precursors
Fig. 6. Npc1−/− mice cerebella display a signiﬁcantly reduced level of Shh transcripts.
Semiquantitative real-time RT-PCR was performed on cerebella of PN8 and PN12
Npc1+/+ (empty bars), Npc1−/− (full bars) and HPBCD-treated Npc1−/− (dashed bars).
Histograms indicate the mean ± SEM of values obtained in three independent assays.
Note that HPBCD re-established the normal level of Shh transcripts. Asterisks indicate sta-
tistically signiﬁcant differences (**p b 0.005).
Fig. 7. Cerebellar granule neurons of Npc1−/−mice exit the cell cycle earlier than those of
wild-type mice. Cerebellar sections of PN11 Npc1+/+ and Npc1−/−mice, either untreated
or treated with a single injection of HPBCD at PN7 (3–4 mice/group; 3–4 sections/mouse)
were immunostained with anti-p27Kip1 antibodies (brown). Nuclei were stained with
methyl green. A representative ﬁeld of ﬁssure between lobules II and III is shown. Note the
presence of scattered p27Kip1-positive GNs along the entire EGL of Npc1−/−. Low and high
magniﬁcation of the same ﬁelds is shown in the right and left panels, respectively. The
HPBCD treatment partially re-established the p27Kip1 expression pattern in Npc1−/−mice.
Numbers (mean ± SEM) of p27Kip-positive GNs/100 μm2 were: Npc1+/+, 17.20 ± 0.81;
Npc1−/−, 21.8 ± 0.79; HPBCD-treated Npc1−/−, 19.20 ± 0.95 (Npc1+/+ vs Npc1−/−, p=
0.03; HPBCD-treated Npc1−/− vs Npc1+/+, p= 0.15; HPBCD-treated Npc1−/− vs Npc1−/−,
p= 0.09). oEGL: outer External Granule Layer; iEGL: inner External Granule Layer. Scale
bars indicate 50 μm (left) and 25 μm (right).
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rise to a shortening of EGL duration in these mice. On the other hand,
we have also observed that EGL thickness is normal until PN11 in
Npc1−/−mice, meaning that the reduced proliferation of GN precursors
does not affect the entire population of GN precursors, which apparent-
ly display timely proliferation and cell cycle exit patterns before PN11.
In fact, under normal conditions, even in the presence of a consistent
population of proliferating GN precursors, a fraction of these cells exit
the cell cycle as early as PN4 (Altman and Bayer, 1997; Espinosa and
Luo, 2008), indicating that not all GN precursors exit the cell cycle at
the same time. Therefore, our observations rule out the possibility that
the development of the overall GN precursor population is defective in
Npc1−/−, suggesting that only longer-lasting GN precursors undergo a
reduction in proliferation activity. This conclusion is supported by the
ﬁnding that the EGL of PN11 Npc1−/− is consistently enriched with
post-mitotic, p27Kip1-positive GNs, distributed along the entire EGL,
whereas the EGL of age-matched wild-type mice still hosts a signiﬁcant
fraction of dividing, p27Kip1-negative GNs in the outer EGL. The lack of
a boundary between the oEGL and iEGL in PN11Npc1−/−mice indicates
that the function of locally-acting signals (Xenaki et al., 2011) is severely
perturbed in the EGL of these mice, likely dysregulating the balance be-
tween GN's proliferation and exit from the cell cycle and accounting for
the shorter-lasting EGL and the decreased GN's proliferation rate ob-
served in these mice.
An additional, but not alternative, explanation for the shorter lasting
EGL of Npc1−/−mice, is that molecular signals sustaining the prolifera-
tion of GN precursors become a limiting factor in Npc1−/−. For instance,
the constant ratio of 175 GNs for each PC (Wetts and Herrup, 1983) led
researchers to postulate that the number of GNs is somehow regulated
by the number and the length of time PCs secrete Shh. Such a model, in
which the reduced expansion of GNs is consequence of reduced avail-
ability of Shh, is in agreement with the reduced level of Shh transcripts
that we measured in PN8 and PN12 Npc1−/−mice. This would also ex-
plainwhy only the proliferation activity of later-lasting GNprecursors is
affected. In fact, while there is no loss of PCs until after P35 (Sarna et al.,
2003), PCs of Npc1−/−mice display a signiﬁcant cholesterol accumula-
tion as early as at PN9 (Reid et al., 2004), making the hypothesis that
the Shh signal becomes defective around this stage reasonable. Howev-
er, in addition to Shh signal generation, mechanisms involved in Shh
signal receptionmight also be involved as they are altered by cholester-
ol (reviewed in Eaton, 2008), cholesterol being an essential componentof lipid raft microdomains containing receptors and/or adhesion mole-
cules. For instance, the hedgehog receptor Patched has recently been
implicated in cholesterol transport (Bidet et al., 2011). Key molecules
controlling Shh-induced proliferation are expressed in a ﬁnely regulat-
ed spatio-temporal manner by a sub-population of GNs residing in a re-
gion of overlap between the oEGL and iEGL. Among these, TAG1 and F3,
belonging to the contactin family, favor GN proliferation and cell cycle
exit, respectively (Xenaki et al., 2011). In light of the complex spatial ar-
rangement of GN subtypes at the level of the EGL, our ﬁnding that
HPBCD treatment partially re-established the p27Kip1 expression pat-
tern in Npc1−/−mice is worth of further investigation.
The very speciﬁc developmental defect identiﬁed by this study pro-
vides novel insights for a better understanding of the cerebellar neuro-
pathology of NPC1 disease. In light of the relevance that the numerical
matching between synaptic partners plays in circuit formation (Sotelo,
1990), our observations now raise the question of whether/how the re-
duction of GN number negatively affects the survival/differentiation of
their synaptic partner, the PCs, and thus contributes to theirﬁnal degen-
eration. However, although this possibility is attractive, at the moment
it is not supported by the present observation that the reduction of GN
number occurs similarly in both the anterior and posterior lobules
Fig. 8. A model of defective GN proliferation in the Npc1−/−.
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ation typical of Npc1−/− mice (Sarna et al., 2003). The interest in the
potential contribution given to PC degeneration by a GN defect(s) has
also been raised by a recent study showing that Npc1−/−mice display
an enhanced parallel ﬁber to PC synaptic transmission and deﬁcient
long-term depression (LTD) (Sun et al., 2001). As a consequence, the in-
creased glutamatergic transmission and LTD deﬁciency may cause PC
chronic excitotoxicity, ﬁnally resulting in neurodegeneration.
Therapies available for NPC1 disease are limited. Among these, the
treatment with the cyclic oligomers of 7-glucose HPBCDs was shown
to rescue cholesterol defects and extend life in mouse models of the
human Niemann–Pick C1 disease (Camargo et al., 2001; Davidson
et al., 2009; Ramirez et al., 2010). This correction requires the endocyto-
sis of the drug (Rosenbaum et al., 2010) and its action is quite similar to
that of NPC2 (McCauliff et al., 2011). Here we have shown that a single
subcutaneous HPBCD injection given at PN7 rescues the GN expansion
defect of Npc1−/−, re-establishing normal patterns of EGL thickness
and also increasing the total number of GNs compared to age-
matched wild-type mice. In vitro studies (Peake and Vance, 2012)
have also shown the efﬁcacy of HPBCD in correcting the cholesterol
storage abnormality in GNs. In vivo, a single HPBCD injection starting
at PN7 Npc1−/− is a frequently used treatment, even though, more re-
cently, the continuous intraventricular administration of HPBCDs in
adult Npc1−/− mice has also been exploited resulting in the mainte-
nance of cerebellar structure if started at day 7 (Aqul et al., 2011). Inter-
estingly, our results show that a single HPBCD treatment apparently
counteracts the premature cell cycle exit of GN precursors, but has a
limited efﬁcacy in re-establishing the sharp boundary between the
outer and inner EGL typical of the normally developing cerebellum.
The ability of HPBCD to rescue the developmental defects of Npc1−/−
GNs can be explained by several mechanisms. Sonic hedgehog (Shh)
contains covalently-bonded cholesterol and either the generation or
the transduction of this signaling could be defective (Incardona and
Eaton, 2000). Cholesterol is needed for the transition of cells from G1
to S phase (Singh et al., 2013) and a relative deﬁciency of cholesterol
at the correct sites in the dividing GNs could slow their divisions.
The ﬁndings of this study pose the question as to whether, besides
the cerebellum, neuron generation is also affected in additional brain re-
gions, either during embryonic or postnatal life, as also suggested by a
study showing that Npc1 deﬁciency impairs the self-renewal ability of
neural stem cells (Yang et al., 2006). Increasing knowledge on this spe-
ciﬁc issue may contribute to the identiﬁcation of novel strategies for
NPC1 disease treatment in our species.Conﬂict of interest
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